{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:05:37Z","timestamp":1793423137628,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Structural Biology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.crstbi.2026.100185","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T17:02:58Z","timestamp":1771866178000},"page":"100185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Computational evaluation of Withania somnifera phytocompounds targeting SARS-CoV-2 ORF9b Protein: Insights from molecular docking, ADMET and MD simulations"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1792-1777","authenticated-orcid":false,"given":"Misha Swetangkumar","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitesh B.","family":"Solanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.crstbi.2026.100185_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2024.105772","article-title":"A multi-target mechanism of Withania somnifera bioactive compounds in autism spectrum disorder (ASD) treatment: network pharmacology, molecular docking, and molecular dynamics simulations studies","volume":"17","author":"Alqahtani","year":"2024","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.crstbi.2026.100185_bib2","author":"Arya","year":"2021"},{"key":"10.1016\/j.crstbi.2026.100185_bib3","series-title":"Insight into the Biological Impact of COVID-19 and its Vaccines on Human Health","author":"Ashwlayan","year":"2022"},{"key":"10.1016\/j.crstbi.2026.100185_bib4","series-title":"An Updated Review on Phytochemistry and Molecular Targets of Withania somnifera (L.) Dunal (Ashwagandha)","author":"Bashir","year":"2023"},{"key":"10.1016\/j.crstbi.2026.100185_bib5","first-page":"1","article-title":"Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors","author":"Bhardwaj","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.crstbi.2026.100185_bib6","series-title":"Withania somnifera (L.) Dunal (Ashwagandha); Current Understanding and Future Prospect as a Potential Drug Candidate","author":"Bhat","year":"2022"},{"issue":"19","key":"10.1016\/j.crstbi.2026.100185_bib7","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.crstbi.2026.100185_bib8","series-title":"WHO Declares COVID-19 a Pandemic","author":"Cucinotta","year":"2020"},{"issue":"Nov","key":"10.1016\/j.crstbi.2026.100185_bib9","article-title":"In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2","volume":"886","author":"Deshpande","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.crstbi.2026.100185_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijbiomac.2021.06.015","article-title":"Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides","volume":"184","author":"Dhanjal","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.crstbi.2026.100185_bib11","doi-asserted-by":"crossref","DOI":"10.18633\/biotecnia.v27.2485","article-title":"Binding affinities analysis of ivermectin, nucleocapsid and ORF6 proteins of SARS-CoV-2 to human importins \u03b1 isoforms: a computational approach","volume":"27","author":"Gayozo","year":"2025","journal-title":"Biotecnia"},{"key":"10.1016\/j.crstbi.2026.100185_bib12","series-title":"Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins","author":"Gorkhali","year":"2021"},{"issue":"12","key":"10.1016\/j.crstbi.2026.100185_bib13","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1080\/07391102.2020.1869588","article-title":"Withanolides from Withania somnifera as an immunity booster and their therapeutic options against COVID-19","volume":"40","author":"Khanal","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"7 July","key":"10.1016\/j.crstbi.2026.100185_bib14","article-title":"Identification of potent inhibitors of HDAC2 from herbal products for the treatment of colon cancer: molecular docking, molecular dynamics simulation, MM\/GBSA calculations, DFT studies, and pharmacokinetic analysis","volume":"19","author":"Khanal","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.crstbi.2026.100185_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1775704","article-title":"Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells","volume":"40","author":"Kumar","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.crstbi.2026.100185_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1775704","article-title":"Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells","volume":"40","author":"Kumar","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"Sep","key":"10.1016\/j.crstbi.2026.100185_bib17","article-title":"SARS-CoV-2 variants alpha, beta, Delta and omicron show a slower host cell interferon response compared to an early pandemic variant","volume":"13","author":"Laine","year":"2022","journal-title":"Front. Immunol."},{"issue":"Sep","key":"10.1016\/j.crstbi.2026.100185_bib18","article-title":"SARS-CoV-2 variants alpha, beta, Delta and omicron show a slower host cell interferon response compared to an early pandemic variant","volume":"13","author":"Laine","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.crstbi.2026.100185_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33103","article-title":"Exploring the therapeutic mechanism of curcumin in prostate cancer using network pharmacology and molecular docking","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.crstbi.2026.100185_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101065","article-title":"A gene set enrichment analysis for cancer hallmarks","volume":"15","author":"Menyhart","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.crstbi.2026.100185_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/6647757","article-title":"Molecular docking, dynamics simulations, ADMET, and DFT calculations: combined in silico approach to screen natural inhibitors of 3CL and PL proteases of SARS-CoV-2","volume":"2024","author":"Mohanasundaram","year":"2024","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.crstbi.2026.100185_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/6647757","article-title":"Molecular docking, dynamics simulations, ADMET, and DFT calculations: combined in silico approach to screen natural inhibitors of 3CL and PL proteases of SARS-CoV-2","volume":"2024","author":"Mohanasundaram","year":"2024","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.crstbi.2026.100185_bib23","series-title":"Side Effects of COVID-19 Vaccines in the Middle Eastern Population","author":"Murished","year":"2023"},{"key":"10.1016\/j.crstbi.2026.100185_bib24","series-title":"Traditional Herbal Medicine Candidates as Complementary Treatments for COVID-19: a Review of their Mechanisms, Pros and Cons","author":"Nugraha","year":"2020"},{"key":"10.1016\/j.crstbi.2026.100185_bib25","unstructured":"M. S. Patel, M. Singh, and M. B. Solanki, \u201ccurrent research in structural biology computational evaluation of Withania somnifera phytocompounds targeting SARS-CoV-2 ORF9b protein: insights from AlphaFold, Molecular Docking, and ADMET Studies-Manuscript Draft-Manuscript Number: Full Title: Computational Evaluation of Withania somnifera Phytocompounds Targeting SARS-CoV-2 ORF9b Protein: Insights from Alphafold, Molecular Docking, and ADMET Studies Powered by Editorial Manager\u00ae and ProduXion Manager\u00ae from Aries Systems Corporation.\u201d."},{"key":"10.1016\/j.crstbi.2026.100185_bib26","series-title":"Phytochemicals of Withania somnifera as a Future Promising Drug Against SARS-CoV-2: Pharmacological Role, Molecular Mechanism, Molecular Docking Evaluation, and Efficient Delivery","author":"Ramli","year":"2023"},{"key":"10.1016\/j.crstbi.2026.100185_bib27","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jcim.5c01056","article-title":"Integrating Chemo- and bioinformatics with in vitro biological assays to discover potential ACE2 and mpro inhibitors against SARS-CoV-2","author":"Ramos","year":"2025","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.crstbi.2026.100185_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1080\/07391102.2020.1810778","article-title":"Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants\u2013Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi)\u2013a molecular docking study","volume":"40","author":"Shree","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.crstbi.2026.100185_bib29","series-title":"Withania somnifera (L.) Dunal (Ashwagandha) for the Possible Therapeutics and Clinical Management of SARS-CoV-2 Infection: Plant-Based Drug Discovery and Targeted Therapy","author":"Singh","year":"2022"},{"issue":"2","key":"10.1016\/j.crstbi.2026.100185_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1039\/D3CB00166K","article-title":"Helix-based screening with structure prediction using artificial intelligence has potential for the rapid development of peptide inhibitors targeting class I viral fusion","volume":"5","author":"Suzuki","year":"2023","journal-title":"RSC Chem. Biol."},{"key":"10.1016\/j.crstbi.2026.100185_bib31","first-page":"1","article-title":"Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor","author":"Tripathi","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.crstbi.2026.100185_bib32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.25081\/jp.2021.v13.7356","article-title":"An in silico approach towards exploration of the oxidative stress resistance of major withanolides of Withania somnifera in relation to COVID-19 management","volume":"13","author":"Vinodkumar","year":"2021","journal-title":"J. Phytol."},{"issue":"1","key":"10.1016\/j.crstbi.2026.100185_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s10020-024-00928-2","article-title":"Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer","volume":"30","author":"Wu","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.crstbi.2026.100185_bib34","series-title":"COVID-19 Pathophysiology: a Review","author":"Yuki","year":"2020"}],"container-title":["Current Research in Structural Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665928X26000061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665928X26000061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:39:07Z","timestamp":1781627947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2665928X26000061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":34,"alternative-id":["S2665928X26000061"],"URL":"https:\/\/doi.org\/10.1016\/j.crstbi.2026.100185","relation":{},"ISSN":["2665-928X"],"issn-type":[{"value":"2665-928X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational evaluation of Withania somnifera phytocompounds targeting SARS-CoV-2 ORF9b Protein: Insights from molecular docking, ADMET and MD simulations","name":"articletitle","label":"Article Title"},{"value":"Current Research in Structural Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crstbi.2026.100185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100185"}}